CHRISTINA MEYER: Open Payments
NPI 1003135229 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 91 payments from 15 companies in 2025. Trend: 2023 $1,618 · 2024 $1,308 · 2025 $1,502
Food & beverage: $1,459Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $451 |
| Novartis Pharmaceuticals Corporation | 15 | $269 |
| Lilly USA, LLC | 14 | $209 |
| GENZYME CORPORATION | 10 | $135 |
| Janssen Biotech, Inc. | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $64 |
| UCB, Inc. | 3 | $59 |
| Incyte Corporation | 2 | $45 |
| Galderma Laboratories, L.P. | 2 | $35 |
Products named: SKYRIZI, COSENTYX, TALTZ, DUPIXENT, RINVOQ, TREMFYA, Bimzelx, OPZELURA.
Industry payments across NE — which companies pay providers there.
